Tritscher A M, Goldstein J A, Portier C J, McCoy Z, Clark G C, Lucier G W
National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.
Cancer Res. 1992 Jun 15;52(12):3436-42.
The mechanisms responsible for the braod spectrum of effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) are not entirely clear but seem to involve an initial interaction with the Ah receptor. A major uncertainty in risk assessment for TCDD is the lack of adequate dose-response relationships following chronic exposure to TCDD. Induction of cytochrome P-450 enzymes (CYP1A1 and CYP1A2) is one of the most sensitive responses to TCDD and its structural analogues. We have used a two-stage model for hepatocarcinogenesis in female Sprague-Dawley rats to evaluate dose-response relationships for induction of CYP1A1 and CYP1A2 in diethylnitrosamine-initiated as well as in noninitiated rats. After initiation with a single dose of diethylnitrosamine, TCDD was administered biweekly by p.o. gavage at doses equivalent to 3.5, 10.7, 35.7, and 125 ng/kg/day for 30 weeks. CYP1A1 and CYP1A2 concentrations were quantified in hepatic microsomes by radioimmunoassay and localized in hepatic tissue slices by immunohistochemical techniques. Radioimmunoassay data revealed a maximum induction of 200-fold for CYP1A1 and 10-fold for CYP1A2 and there were no statistically significant differences between initiated and noninitiated rats. Induction at the lowest dose (3.5 ng/kg/day) was 20-fold for CYP1A1 and 3-fold for CYP1A2. Mathematical analysis indicates that the best fit of the induction data are inconsistent with a threshold for this response. There was a linear relationship between administered dose and TCDD liver concentration over the entire dose range of the study. This indicates that induction of CYP1A2 does not significantly alter the distribution of TCDD in our chronic dosing regimen. Immunolocalization of CYP1A1 and CYP1A2 revealed the same localization and induction pattern for both isozymes in the cytoplasm of hepatocytes. However, the hepatic distribution pattern was not uniform with the most intense staining observed around central veins. These studies help to clarify dose-response relationships for dioxin-mediated effects and demonstrate different sensitivity of hepatocytes to the effects of TCDD.
2,3,7,8-四氯二苯并对二恶英(TCDD)产生广泛影响的机制尚不完全清楚,但似乎涉及与芳烃受体的初始相互作用。TCDD风险评估中的一个主要不确定因素是长期接触TCDD后缺乏充分的剂量反应关系。细胞色素P-450酶(CYP1A1和CYP1A2)的诱导是对TCDD及其结构类似物最敏感的反应之一。我们使用雌性Sprague-Dawley大鼠肝癌发生的两阶段模型,来评估二乙基亚硝胺启动组和未启动组大鼠中CYP1A1和CYP1A2诱导的剂量反应关系。单次给予二乙基亚硝胺启动后,TCDD以相当于3.5、10.7、35.7和125 ng/kg/天的剂量每周两次经口灌胃给药,持续30周。通过放射免疫测定法定量肝微粒体中CYP1A1和CYP1A2的浓度,并通过免疫组织化学技术在肝组织切片中定位。放射免疫测定数据显示,CYP1A1的最大诱导倍数为200倍,CYP1A2为10倍,启动组和未启动组大鼠之间无统计学显著差异。最低剂量(3.5 ng/kg/天)时,CYP1A1的诱导倍数为20倍,CYP1A2为3倍。数学分析表明,诱导数据的最佳拟合与该反应的阈值不一致。在研究的整个剂量范围内,给药剂量与TCDD肝脏浓度之间存在线性关系。这表明在我们的长期给药方案中,CYP1A2的诱导不会显著改变TCDD的分布。CYP1A1和CYP1A2的免疫定位显示,两种同工酶在肝细胞胞质中的定位和诱导模式相同。然而,肝脏分布模式并不均匀,在中央静脉周围观察到最强的染色。这些研究有助于阐明二恶英介导效应的剂量反应关系,并证明肝细胞对TCDD效应的不同敏感性。